BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16498360)

  • 1. Aromatase and prostate cancer.
    Ellem SJ; Risbridger GP
    Minerva Endocrinol; 2006 Mar; 31(1):1-12. PubMed ID: 16498360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase and regulating the estrogen:androgen ratio in the prostate gland.
    Ellem SJ; Risbridger GP
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):246-51. PubMed ID: 19896534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of estrogens in development of prostate cancer.
    Härkönen PL; Mäkelä SI
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):297-305. PubMed ID: 15663993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase enzyme and Alzheimer's disease.
    Hiltunen M; Iivonen S; Soininen H
    Minerva Endocrinol; 2006 Mar; 31(1):61-73. PubMed ID: 16498364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dual, opposing roles of estrogen in the prostate.
    Ellem SJ; Risbridger GP
    Ann N Y Acad Sci; 2009 Feb; 1155():174-86. PubMed ID: 19250203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymes as modulators in malignant transformation.
    Vihko P; Herrala A; Härkönen P; Isomaa V; Kaija H; Kurkela R; Li Y; Patrikainen L; Pulkka A; Soronen P; Törn S
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):277-83. PubMed ID: 15860271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
    Takahashi-Shiga N; Utsunomiya H; Miki Y; Nagase S; Kobayashi R; Matsumoto M; Niikura H; Ito K; Yaegashi N
    Clin Cancer Res; 2009 Oct; 15(19):6028-34. PubMed ID: 19789322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of type 2 3alpha-hydroxysteroid dehydrogenase/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma.
    Fung KM; Samara EN; Wong C; Metwalli A; Krlin R; Bane B; Liu CZ; Yang JT; Pitha JV; Culkin DJ; Kropp BP; Penning TM; Lin HK
    Endocr Relat Cancer; 2006 Mar; 13(1):169-80. PubMed ID: 16601286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-androgenic action by red clover-derived dietary isoflavones reduces non-malignant prostate enlargement in aromatase knockout (ArKo) mice.
    Jarred RA; McPherson SJ; Jones ME; Simpson ER; Risbridger GP
    Prostate; 2003 Jun; 56(1):54-64. PubMed ID: 12746847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of androgen/estrogen ratio: lessons learned from the aromatase over-expression mice.
    Li X; Rahman N
    Gen Comp Endocrinol; 2008 Oct; 159(1):1-9. PubMed ID: 18762187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogens and prostate cancer.
    Risbridger GP; Bianco JJ; Ellem SJ; McPherson SJ
    Endocr Relat Cancer; 2003 Jun; 10(2):187-91. PubMed ID: 12790781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.
    Wu Q; Zhou Y; Chen L; Shi J; Wang CY; Miao L; Klocker H; Park I; Lee C; Zhang J
    J Endocrinol; 2007 Oct; 195(1):89-94. PubMed ID: 17911400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of aromatase expression in breast cancer tissue.
    Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
    Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogens and mechanisms of prostate cancer progression.
    Carruba G
    Ann N Y Acad Sci; 2006 Nov; 1089():201-17. PubMed ID: 17261768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular regulation of androgen action in prostate cancer.
    Dehm SM; Tindall DJ
    J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective spatial upregulation of intratumoral stromal aromatase in breast cancer patients: evidence for imbalance of local estrogen metabolism.
    Singer CF; Fink-Retter A; Gschwantler-Kaulich D; Thalhammer T; Hudelist G; Mueller R; Czerwenka K; Kubista E
    Endocr Relat Cancer; 2006 Dec; 13(4):1101-7. PubMed ID: 17158756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
    Ho SM
    J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.